Sarepta Therapeutics Inc. (0L35)
Market Open
16 Oct, 03:30 PM
$
17. 05
-0.45
-2.5436%
$
- Market Cap
- P/E Ratio
- Div Yield
2,128 Volume
-6.99 Eps
$ 17.5
Previous Close Want to track 0L35 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sarepta Therapeutics Inc. (0L35) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.28B
Trailing P/E (ttm) -11.87
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.91
Price/Book (mrq) 1.18
Enterprise Value/Revenue 1.16
Enterprise Value/EBITDA -156.4
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.8K
Average volume (90 days) 7.27K
Price summary
52-Week low 14.35
52-Week high 24.75
Beta -
50-Day moving average 19.34
200-Day moving average 18.68
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 12 Jul 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.07%
Operating margin -0.07%
Operational effectiveness
Return on assets -0.04%
Return on equity -0.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 18.73
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.48
Total debt (mrq) -
Total Debt/Equity (mrq) 0.68
Current ratio (mrq) 4.42%
Book value per share (mrq) 14.49
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
